{
    "cancelStatus": "0",
    "licStatus": "1",
    "cancelDate": null,
    "cancelReason": [],
    "otherCancelReason": "",
    "licid": "10000918",
    "licUnit": "1",
    "validDate": "2026-08-18 00:00:00.000",
    "issueDate": "2011-08-18 00:00:00.000",
    "licKind": "04",
    "oldLicid": null,
    "certNo": "DHA01000091802",
    "prodNameC": "保骼麗注射液",
    "prodNameE": "Prolia",
    "indicationsName": [
        "治療有骨折高風險性之停經後婦女骨質疏鬆症。說明：有骨折高風險性之停經後婦女骨質疏鬆症，包含下列任一狀況：有骨質疏鬆症骨折病史、具有多項骨折危險因子、先前接受其他骨質疏鬆症療法失敗或無法耐受其他骨質疏鬆症療法之病患。對患有骨質疏鬆症之停經後婦女，Prolia可降低脊椎、非脊椎和髖骨骨折的發生率。\r\n治療有高度骨折風險之骨質疏鬆症男性患者，以增加骨量(bone mass)。說明：Prolia 適用於治療有高度骨折風險(定義為有骨質疏鬆症骨折病史，或具有多項骨折危險因子)之骨質疏鬆症男性患者，或先前曾接受其他骨質疏鬆症療法失敗或無法耐受其他骨質疏鬆症療法的患者，以增加骨量(bone mass)。治療因為非轉移性攝護腺癌而進行雄性荷爾蒙抑制治療且具高度骨折風險之男性患者的骨質流失現象。\r\n治療糖皮質類固醇引起的骨質疏鬆症。說明：Prolia適用於治療有高度骨折風險的糖皮質類固醇引起之骨質疏鬆症男性與女性病人，他們正開始或持續每日劑量等效於7.5毫克prednisone或以上的全身性糖皮質類固醇，並預計維持使用糖皮質類固醇至少6個月。高度骨折風險的定義為發生過骨質疏鬆性骨折、具有多重骨折風險因子、或曾接受其他骨質疏鬆症治療失敗或耐受不良的病人。"
    ],
    "does": "2270",
    "packageUnit": [
        {
            "packageSpec": "單劑量1mL包於或未包於塑膠套中之",
            "packageUnit": "2K"
        },
        {
            "packageSpec": "100支以下",
            "packageUnit": "03"
        }
    ],
    "medMCode": "05",
    "maMedCode": null,
    "medDCode": null,
    "mainCategory": null,
    "drBaseId": "B42FA618-FBE5-462A-80B2-E7783FEE9ADC",
    "subCategory": [],
    "ingredientsDesc": [
        "Denosumab"
    ],
    "restraintItemsCode": [
        "02",
        "07",
        "1D"
    ],
    "applicantName": "台灣安進藥品有限公司 ",
    "applicantAddr": "臺北市信義區松仁路100號13樓之1、之2",
    "medClass": null,
    "efficacy": " ",
    "mdFormat": null,
    "productAnnotation": null,
    "mdKind": [],
    "monitorDate": null,
    "licidNew": null,
    "licidOld": null,
    "factoryDtoList": [
        {
            "factoryCode": "1",
            "factoryName": "AMGEN MANUFACTURING, LIMITED",
            "factoryAddr": "STATE ROAD 31, KILOMETER 24.6, JUNCOS, PUERTO RICO 00777",
            "factoryCompanyAddr": null,
            "countryCode": "PR",
            "processCode": [
                {
                    "value": "66",
                    "name": "成品製造廠"
                }
            ],
            "processCodeStr": "66;成品製造廠",
            "factoryKind": "M",
            "factoryNo": "FPR0034000",
            "factoryInfo": null,
            "qsd": null,
            "qsdList": [],
            "factoryMadeIn": null
        },
        {
            "factoryCode": "2",
            "factoryName": "AMGEN SINGAPORE MANUFACTURING PTE. LTD.",
            "factoryAddr": "1 TUAS VIEW DRIVE, SINGAPORE 637026",
            "factoryCompanyAddr": "",
            "countryCode": "SG",
            "processCode": [
                {
                    "value": "65",
                    "name": "主成分(drug substance)製造廠"
                }
            ],
            "processCodeStr": "65;主成分(drug substance)製造廠",
            "factoryKind": "M",
            "factoryNo": "FSG0046000",
            "factoryInfo": null,
            "qsd": null,
            "qsdList": [],
            "factoryMadeIn": null
        }
    ],
    "ingredientsDtoList": [
        {
            "ingredientsKind": "1",
            "ingredientsCode": "1013002600",
            "ingredientsName": "Denosumab",
            "ingredientsDesc": "Denosumab",
            "concentDesc": null,
            "concent": "60.0000",
            "concentUnit": "001",
            "seq": "1",
            "prescription_seq": "1",
            "prescription_Kind": "1"
        }
    ],
    "authDtoList": [],
    "iomDtoList": [],
    "changeDtoList": [],
    "atcList": [
        {
            "isMain": "1",
            "atcCode": "M05BX04"
        }
    ],
    "licBaseId": "6996E265-ECA3-40F9-B384-B2B8BA47B367"
}